Materias dentro de su búsqueda.
Materias dentro de su búsqueda.
Riñones
33
Enfermedades
24
Enfermería
13
Fisiología
8
Insuficiencia renal
7
Insuficiencia renal crónica
6
Nutrición
5
Tratamiento
5
Aparato urinario
4
Dietoterapia
4
Diálisis
4
Nefrología
4
Química clínica
4
Trasplantes de riñones
4
Diagnóstico
3
Licenciado en Enfermería
3
Aspectos nutricionales
2
Atención al paciente
2
Atlas
2
Cirugía
2
Dieta para enfermos
2
Farmacología
2
Farmacología clínica
2
Fisiología renalAparato urinario
2
Fisiopatología
2
Fisiopatología de riñones
2
Hemodiálisis
2
Medicina
2
Medicina clínica
2
Urología pediátrica
2
-
101741por Röhl, C., Batke, M., Damm, G., Freyberger, A., Gebel, T., Gundert-Remy, U., Hengstler, J. G., Mangerich, A., Matthiessen, A., Partosch, F., Schupp, T., Wollin, K. M., Foth, H.“…BMD modeling with model averaging for renal cancer studies (Kurokawa et al., J Natl. Cancer Inst, 1983 and 1986a; DeAngelo et al., Toxicol Pathol 26:587–594, 1998) resulted in a median hBMDL(10) of 0.65 mg bromate/kg body weight (bw) per day. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
101742por Lei, Yuanli, Liu, Jinying, Lin, Yi, Li, Huiping, Song, Wenxing, Li, Zhangping, Huang, Weijia, Chen, Shouquan“…The maximum SMA diameter was 12.1 (11.3–13.1) mm, and the maximum SMA diameter was located on the left renal vein (LRV) plane in 68.2% of cases. Dissection features observed on contrast-enhanced CT (CECT), CT angiography (CTA), or digital subtraction angiography (DSA) showed that there were 70 cases (63.6%) of Yun type IIb SISMAD, the maximum SMA diameter was 13.0 ± 2.4 mm, the location of the maximum SMA diameter was on the LRV plane in 64.5% of cases, and 7.3% of cases were complicated with intestinal obstruction, including bowel necrosis in 3.6% of cases. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
101743por Helleputte, Simon, Van Bortel, Luc, Verbeke, Francis, Op ‘t Roodt, Jos, Calders, Patrick, Lapauw, Bruno, De Backer, Tine“…Ambulatory 24-h blood pressure and central hemodynamic parameters were evaluated. Data on renal function and diabetic kidney disease was retrieved. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
101744por Badri, Prajakta, Jiang, Xuemin, Borodovsky, Anna, Najafian, Nader, Kim, Jae, Clausen, Valerie A., Goel, Varun, Habtemariam, Bahru, Robbie, Gabriel J.“…RESULTS: In HVs, cemdisiran was rapidly converted to a major active metabolite, AS(N-2)3′-cemdisiran, both declining below the lower limit of quantification (LLOQ) in plasma within 48 h, and showing minimal renal excretion. AS(N-2)3′-cemdisiran exhibited more than dose-proportional PK. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
101745por Caskey, Fergus J., Procter, Sunita, MacNeill, Stephanie J., Wade, Julia, Taylor, Jodi, Rooshenas, Leila, Liu, Yumeng, Annaw, Ammar, Alloway, Karen, Davenport, Andrew, Power, Albert, Farrington, Ken, Mitra, Sandip, Wheeler, David C., Law, Kristian, Lewis-White, Helen, Ben-Shlomo, Yoav, Hollingworth, Will, Donovan, Jenny, Lane, J. Athene“…Follow-up data will be collected by linkage to routine healthcare databases — Hospital Episode Statistics, Civil Registration, Public Health England and the UK Renal Registry (UKRR) in England, and equivalent databases in Scotland and Wales, as necessary — and centrally administered patient-completed questionnaires. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
101746por Herrmann, Johannes, Lotz, Christopher, Karagiannidis, Christian, Weber-Carstens, Steffen, Kluge, Stefan, Putensen, Christian, Wehrfritz, Andreas, Schmidt, Karsten, Ellerkmann, Richard K., Oswald, Daniel, Lotz, Gösta, Zotzmann, Viviane, Moerer, Onnen, Kühn, Christian, Kochanek, Matthias, Muellenbach, Ralf, Gaertner, Matthias, Fichtner, Falk, Brettner, Florian, Findeisen, Michael, Heim, Markus, Lahmer, Tobias, Rosenow, Felix, Haake, Nils, Lepper, Philipp M., Rosenberger, Peter, Braune, Stephan, Kohls, Mirjam, Heuschmann, Peter, Meybohm, Patrick“…Additional factors associated with survival were younger age, shorter time between intubation and ECMO initiation, BMI > 35 (compared to < 25), absence of renal replacement therapy or major bleeding/thromboembolic events. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
101747por Ermer, Theresa, Canavan, Maureen E., Maduka, Richard C., Li, Andrew X., Salazar, Michelle C., Kaminski, Michael F., Pichert, Matthew D., Zhan, Peter L., Mase, Vincent, Kluger, Harriet, Boffa, Daniel J.“…A total of 402 689 patients 20 years or older who were diagnosed with stage IV non–small cell lung cancer (NSCLC), renal cell carcinoma (RCC), or melanoma of the skin between January 1, 2007, and December 31, 2018 (specific years varied by tumor type), were included. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
101748por Schillemans, Tessa, Tragante, Vinicius, Maitusong, Buamina, Gigante, Bruna, Cresci, Sharon, Laguzzi, Federica, Vikström, Max, Richards, Mark, Pilbrow, Anna, Cameron, Vicky, Foco, Luisa, Doughty, Robert N., Kuukasjärvi, Pekka, Allayee, Hooman, Hartiala, Jaana A., Tang, W. H. Wilson, Lyytikäinen, Leo-Pekka, Nikus, Kjell, Laurikka, Jari O., Srinivasan, Sundararajan, Mordi, Ify R., Trompet, Stella, Kraaijeveld, Adriaan, van Setten, Jessica, Gijsberts, Crystel M., Maitland-van der Zee, Anke H., Saely, Christoph H., Gong, Yan, Johnson, Julie A., Cooper-DeHoff, Rhonda M., Pepine, Carl J., Casu, Gavino, Leiherer, Andreas, Drexel, Heinz, Horne, Benjamin D., van der Laan, Sander W., Marziliano, Nicola, Hazen, Stanley L., Sinisalo, Juha, Kähönen, Mika, Lehtimäki, Terho, Lang, Chim C., Burkhardt, Ralph, Scholz, Markus, Jukema, J. Wouter, Eriksson, Niclas, Åkerblom, Axel, James, Stefan, Held, Claes, Hagström, Emil, Spertus, John A., Algra, Ale, de Faire, Ulf, Åkesson, Agneta, Asselbergs, Folkert W., Patel, Riyaz S., Leander, Karin“…The results from stratified analyses showed null results, except for significant inverse associations between rs7672915 (intron 2) and the primary outcome among 1) individuals aged ≥65, 2) individuals with renal impairment, and 3) antiplatelet users. Conclusion: We found no clear associations between polymorphisms in the PPARGC1A gene and subsequent CHD events in patients with established CHD at baseline.…”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
101749por Hughes, Stephen Fôn, Moyes, Alyson Jayne, Jones, Kevin, Bell, Christopher, Duckett, Abigail, Moussa, Ahmed, Shergill, Iqbal“…Pre-operative stone information included the size (mm), Hounsfield units (HU), laterality and intra-renal anatomical location. Peri-operative surgical details included surgical time in minutes; Laser use; Duration and energy of laser; and post-operative stenting. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
101750por Wang, Zhuang, Heid, Bettina, Lu, Ran, Sachdeva, Mohit, Edwards, Michael R., Ren, JingJing, Cecere, Thomas E., Khan, Deena, Jeboda, Taschua, Kirsch, David G., Reilly, Christopher M., Dai, Rujuan, Ahmed, S. Ansar“…The miR-182(−/−)B6/lpr and miR-183C(−/−)B6/lpr mice had significantly reduced deposition of IgG immunocomplexes in the kidney when compared to their respective littermate controls, although there appeared to be no remarkable changes in renal pathology. Importantly, we observed a significant reduction of serum anti-dsDNA autoantibodies in miR-183C(−/−)B6/lpr mice after reaching 24 weeks-of age compared to age-matched miR-183C(fl/fl)B6/lpr controls. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
101751por Sansone, Nathália MS, Boschiero, Matheus N, Valencise, Felipe E, Palamim, Camila VC, Marson, Fernando AL“…Also, among the comorbidities, the main predictors were the presence of immunosuppressive disorder (OR = 1.44; 95% CI = 1.39-1.49), neurological disorder (OR = 1.21; 95% CI = 1.17-1.25), hepatic disorder (OR = 1.41; 95% CI = 1.34-1.50), diabetes mellitus (OR = 1.40; 95% CI = 1.37-1.42), cardiopathy (OR = 1.13; 95%CI = 1.11-1.14), hematologic disorder (OR = 1.34; 95% CI = 1.24-1.43), Down syndrome (OR = 1.61; 95% CI = 1.43-1.81), renal disease (OR = 1.15; 95% CI = 1.11-1.18), and obesity (OR = 1.18; 95% CI = 1.15-1.21). …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
101752por Lei, Nuo, Zhang, Xianlong, Wei, Mengting, Lao, Beini, Xu, Xueyi, Zhang, Min, Chen, Huifen, Xu, Yanmin, Xia, Bingqing, Zhang, Dingjun, Dong, Chendi, Fu, Lizhe, Tang, Fang, Wu, Yifan“…The sample size of these 6 studies was 12,534, and the kidney disease types could be divided into chronic kidney disease (CKD) and Immunoglobulin A Nephropathy, with 5 articles using end-stage renal diseases occurrence as the primary outcome. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
101753por Kho, Marcia M. L., Weimar, Willem, Malahe, S. Reshwan K., Zuijderwijk, Joke M., de Kuiper, Ronella, Boer-Verschragen, Marieken J., van der Eijk, Annemiek A., Hesselink, Dennis A., Reinders, Marlies E. J., van Besouw, Nicole M.“…Booster vaccination could prevent HZ. However, end-stage renal disease (ESRD) patients show poor immunological responses to vaccinations. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
101754por Tomizawa, Daisuke, Saito, Akiko Moriya, Taga, Takashi, Adachi, Souichi, Nakayama, Hideki, Moritake, Hiroshi, Azuma, Eiichi, Kinoshita, Akitoshi, Takahashi, Hiroyuki, Imaizumi, Masue, Kudo, Kazuko, Hama, Asahito, Tsurusawa, Masahito, Horibe, Keizo, Tawa, Akio“…When comparing the infant group (N=27) and the older age group (≥ 1 year, N=221), there were no difference in hematological toxicities, however, non-hematological toxicities, such as renal, cardiac, pulmonary, neurological complications, and tumor lysis syndrome were significantly more common in the infant group. …”
Publicado 2010
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
101755por Valle-Hita, Cristina, Díaz-López, Andrés, Becerra-Tomás, Nerea, Martínez-González, Miguel A., García, Verónica Ruiz, Corella, Dolores, Goday, Albert, Martínez, J. Alfredo, Alonso-Gómez, Ángel M., Wärnberg, Julia, Vioque, Jesús, Romaguera, Dora, López-Miranda, José, Estruch, Ramon, Tinahones, Francisco J., Lapetra, José, Serra-Majem, Luís, Cano-Ibáñez, Naomi, Tur, Josep A., Rubín-García, María, Pintó, Xavier, Delgado-Rodríguez, Miguel, Matía-Martín, Pilar, Vidal, Josep, Fontao, Sebastian Mas, Daimiel, Lidia, Ros, Emilio, Toledo, Estefania, Sorlí, José V., Roca, C., Abete, Iztiar, Moreno-Rodriguez, Anai, Crespo-Oliva, Edelys, Candela-García, Inmaculada, Morey, Marga, Garcia-Rios, Antonio, Casas, Rosa, Fernandez-Garcia, Jose Carlos, Santos-Lozano, José Manuel, Diez-Espino, Javier, Ortega-Azorín, Carolina, Comas, M., Zulet, M. Angeles, Sorto-Sanchez, Carolina, Ruiz-Canela, Miguel, Fitó, Montse, Salas-Salvadó, Jordi, Babio, Nancy“…RESULTS: Participants in the highest tertile of increase in 17-item erMedDiet Score showed higher upward changes in eGFR (β: 1.87 ml/min/1.73m(2); 95% CI: 1.00–2.73) and had lower odds of ≥ 10% eGFR decline (OR: 0.62; 95% CI: 0.47–0.82) compared to individuals in the decrease/maintenance category, while Trichopoulou-MedDiet and DASH Scores were not associated with any renal outcomes. Those in the highest tertile of increase in Protein Diet Score had greater downward changes in eGFR (β: − 0.87 ml/min/1.73m(2); 95% CI: − 1.73 to − 0.01) and 32% higher odds of eGFR decline (OR: 1.32; 95% CI: 1.00–1.75). …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
101756por Lin, Xue-Yan, Zeng, Yi, Zhang, Zheng-Chao, Lin, Zhi-Hui, Chen, Lu-Chuan, Ye, Zai-Sheng“…Decreased serum TG levels are treated by non-invasive methods, which include anti-lipidemic agents, heparin, low-molecular weight heparin, and insulin, and invasive methods, such as blood purification including hemoperfusion (HP), plasmapheresis, and continuous renal replacement therapy. However, authoritative guidelines have not been established. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
101757por Xu, Bowen, Wang, Xinmiao, Wang, Heping, Cao, Luchang, Ge, Yuansha, Yuan, Bo, Gao, Ruike, Li, Jie“…There were no significant differences in ORR [RR = 1.32, 95% CI (0.94~1.86)] and DCR [RR = 1.22, 95% CI (0.99~1.50)], but they can improve the KPS response rate [RR = 1.62, 95% CI (1.13, 2.32)] and decrease the incidence of myelosuppression, nausea and vomiting, diarrhea, and hepatic and renal dysfunction in CRC. CONCLUSION: This study indicates that herbal formulas that could regulate the composition and proportion of gut microbiota have a positive effect in three stages (perioperative, postoperative, and advanced) of GC and CRC. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
101758por Leccisotti, Lucia, Cinti, Francesca, Sorice, Gian Pio, D’Amario, Domenico, Lorusso, Margherita, Guzzardi, Maria Angela, Mezza, Teresa, Gugliandolo, Shawn, Cocchi, Camilla, Capece, Umberto, Indovina, Luca, Ferraro, Pietro Manuel, Iozzo, Patricia, Crea, Filippo, Giordano, Alessandro, Giaccari, Andrea“…The groups were well-matched for baseline characteristics (age, diabetes duration, HbA1c, renal and heart function). There was no significant change in MGU during euglycemic hyperinsulinemic clamp in the dapagliflozin group (2.22 ± 0.59 vs 1.92 ± 0.42 μmol/100 g/min, p = 0.41) compared with the placebo group (2.00 ± 0.55 vs 1.60 ± 0.45 μmol/100 g/min, p = 0.5). …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
101759por Assis, Francis Sampaio de, Spadacio, José Victor Bolotari, Jorge, Luciana Souza, Almeida, Vanessa Soares de Oliveira e, Gonzales, Aline da Silva, Castro, Paulo de Tarso Oliveira e, Silveira, Gabriela Gomes, Junior, José Carlos Ignacio, Prado, Seila Israel do“…Aos exames, apresentava anemia, linfopenia, plaquetopenia e neutrofilia, presença de esquizófitos, além de provas inflamatórias alteradas, alargamento de INR, hipoalbuminemia e hiperbilirrubinemia, injuria renal aguda sem hipercalemia e sem dismorfismo eritrocitário, consumo de complemento, haptoglobina reduzida, coombs direto negativo e hemoculturas negativas. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
101760por Santos, Nanci Michele Saita, Garcia, Marcia Teixeira, Ferreira, Amanda Tereza, Silva, Michele de Freitas Neves, Mendes, Elisa Donalisio Teixeira, de Agrela, Marcus Vinicius Rodrigues, Martins, Antonio Camargo, Angerami, Rodrigo Nogueira, Hofling, Christian Cruz, Resende, Mariangela Ribeiro“…Quanto as comorbidades, 29,0% faziam uso de álcool, 21,0% de drogas, 21,0% tinham doença renal, 7,0% HIV, 7,0% diabetes. Em relação ao desfecho dos casos durante a internação, 9 (64%) casos receberam alta hospitalar e 5 (36,0%) foram a óbito. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Online Artículo Texto